BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

  April 7, 2025

   · 

  5 min read
• Press Releases

  Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors

  April 7, 2025

   · 

  3 min read
• Press Releases

  Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

  April 7, 2025

   · 

  4 min read
• Press Releases

  NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

  April 7, 2025

   · 

  8 min read
• Press Releases

  Stryker to announce financial results for its first quarter of fiscal year 2025

  April 7, 2025

   · 

  1 min read
• Press Releases

  Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum

  April 7, 2025

   · 

  2 min read
• Press Releases

  Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology

  April 7, 2025

   · 

  4 min read
• Press Releases

  Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

  April 7, 2025

   · 

  7 min read
• Press Releases

  Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting

  April 7, 2025

   · 

  2 min read
• Press Releases

  Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors

  April 7, 2025

   · 

  2 min read